Defence Therapeutics【DTC】銘柄情報

	リアルタイム株価	レベル2
Forex

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.54

買値

0.51

売値

0.57

出来高

1,500

0.54 日の範囲 0.54

0.48 52 週間の範囲 2.85

前日終値

0.51

始値

0.54

時刻

1500

0.54

最終取引時間

平均取引量 (3 か月)

26,135

財務取引量

VWAP

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9 Vancouver, BC, Canada, January 26th...

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS Vancouver, BC, Canada, November...

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER Vancouver, BC, Canada, October 13th...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01	-1.81818181818	0.55	0.57	0.51	7256	0.51241173	CS
4	-0.05	-8.47457627119	0.59	0.67	0.51	21719	0.57849862	CS
12	-0.06	-10	0.6	0.67	0.48	26135	0.5764456	CS
26	-0.66	-55	1.2	1.2	0.48	31835	0.73685318	CS
52	-2.14	-79.8507462687	2.68	2.85	0.48	29024	1.18019255	CS
156	-5.11	-90.4424778761	5.65	5.8	0.48	19066	2.18673433	CS
260	-1.21	-69.1428571429	1.75	8.15	0.48	18376	2.60901261	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
GTTXGeneTether Therapeutics Inc	$ 0.11 (175.00%)	2k
EPIC1CM Inc	$ 0.60 (140.00%)	1.12k
CHGXChitogenX Inc	$ 0.01 (100.00%)	5k
CACR.AKWG Resources Inc	$ 2.31 (71.11%)	100
CLDVCloud3 Ventures Inc	$ 0.025 (66.67%)	4.89M
MLKMMayo Lake Minerals Inc	$ 0.025 (-50.00%)	373k
WRUNWaverunner Capital Inc	$ 0.005 (-50.00%)	105.49k
SLZSlave Lake Zinc Corp	$ 0.01 (-50.00%)	9k
MILIMilitary Metals Corp	$ 0.345 (-47.73%)	2.28M
VIBEVibe Growth Corporation	$ 0.11 (-47.62%)	1.5k
RGXRegenx Tech Corp	$ 0.01 (-33.33%)	5.25M
CLDVCloud3 Ventures Inc	$ 0.025 (66.67%)	4.89M
PRMEPrime Drink Group Corp	$ 0.315 (5.00%)	3M
MILIMilitary Metals Corp	$ 0.345 (-47.73%)	2.28M
BTCBluesky Digital Assets Corp	$ 0.74 (-6.33%)	2.12M